|
|
Blood, 15 December 2006, Vol. 108, No. 13, pp. 4118-4125.
Prepublished online as a Blood First Edition Paper on August 10, 2006; DOI 10.1182/blood-2006-03-006700.
Previous Article | Next Article 
Submitted March 2, 2006
Accepted July 25, 2006
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46 and NKG2D activating receptors and regulates NK cell function
Mariella Della Chiesa, Simona Carlomagno, Guido Frumento, Mirna Balsamo, Claudia Cantoni, Romana Conte, Lorenzo Moretta, Alessandro Moretta*, and Massimo Vitale
DI.ME.S. Dipartimento di Medicina Sperimentale Universita di Genova, Genova, Italy
IST - Istituto Nazionale per la Ricerca sul Cancro - Genova, Italy
Istituto G. Gaslini - Genova-Quarto, Italy
Istituto G. Gaslini - Genova, Italy
IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
* Corresponding author; email: alemoret{at}unige.it.
ABSTRACT
Tryptophan (Trp) catabolism mediated by indoleamine 2,3-dioxygenase (IDO) plays a central role in the regulation of T cell-mediated immune responses. In this study we demonstrate that also NK cell function can be influenced by IDO. Indeed, L-kynurenine, a Trp-derived catabolite resulting from IDO activity, was found to prevent the cytokine-mediated up-regulation of the expression and function of specific triggering receptors responsible for the induction of NK cell-mediated killing. The effect of L-kynurenine appears to be restricted to NKp46 and NKG2D, while it does not affect other surface receptors such as NKp30 or CD16. As a consequence, L-kynurenine-treated NK cells display impaired ability to kill target cells recognized via NKp46 and NKG2D. Instead, they maintain the ability to kill targets, such as Dendritic Cells (DC), that are mainly recognized via the NKp30 receptor. The effect of L-kynurenine, which is effective both at the transcriptional and at the protein level, can be reverted, since NK cells were found to recover their functional competence after washing.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Chung, M. Rossi, E. Romano, J. Ghith, J. Yuan, D. H. Munn, and J. W. Young
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
Blood,
July 16, 2009;
114(3):
555 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oberlies, C. Watzl, T. Giese, C. Luckner, P. Kropf, I. Muller, A. D. Ho, and M. Munder
Regulation of NK Cell Function by Human Granulocyte Arginase
J. Immunol.,
May 1, 2009;
182(9):
5259 - 5267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yoshida, K. Ino, Y. Ishida, H. Kajiyama, E. Yamamoto, K. Shibata, M. Terauchi, A. Nawa, H. Akimoto, O. Takikawa, et al.
Overexpression of Indoleamine 2,3-Dioxygenase in Human Endometrial Carcinoma Cells Induces Rapid Tumor Growth in a Mouse Xenograft Model
Clin. Cancer Res.,
November 15, 2008;
14(22):
7251 - 7259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-K. Shen, D. Filopon, H. Chaker, S. Boullanger, M. Derouazi, B. Polack, and B. Toussaint
High-cell-density regulation of the Pseudomonas aeruginosa type III secretion system: implications for tryptophan catabolites
Microbiology,
August 1, 2008;
154(8):
2195 - 2208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Le Maux Chansac, D. Misse, C. Richon, I. Vergnon, M. Kubin, J.-C. Soria, A. Moretta, S. Chouaib, and F. Mami-Chouaib
Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway
Int. Immunol.,
July 1, 2008;
20(7):
801 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ino, E. Yamamoto, K. Shibata, H. Kajiyama, N. Yoshida, M. Terauchi, A. Nawa, T. Nagasaka, O. Takikawa, and F. Kikkawa
Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
Clin. Cancer Res.,
April 15, 2008;
14(8):
2310 - 2317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Blood,
February 1, 2008;
111(3):
1327 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, A. Meinhardt, M.-E. Roehrich, D. Golshayan, J. Dudler, M. Pagnotta, M. Trucco, and G. Vassalli
Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival
Am J Physiol Heart Circ Physiol,
December 1, 2007;
293(6):
H3415 - H3423.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|